Study questions Lipitor’s efficacy for women
NEW YORK A study published in the Journal of Empirical Legal Studies has shown that Pfizer’s blockbuster drug Lipitor does little to reduce the risk of cardiovascular problems in women.
The study was based on analysis of previous studies on drugs’ effects on cardiovascular health in men and women. Studies had shown that the reduction in heart attack risk was statistically significant in men who used Lipitor (atorvastatin calcium), but not in women.
“Our findings indicate that each year, reasonably health women spend billions of dollars on drugs in the hope of preventing heart attacks but that scientific evidence supporting their hope does not exist.”
Save Mart guarantees prescription filling in 19 minutes or less
MODESTO, Calif. In an effort to provide faster service, Save Mart Supermarkets has announced that its Save Mart and Lucky banners will guarantee an order of up to three prescriptions filled within 19 minutes.
Customers whose prescriptions take longer than 19 minutes to fill will receive Save Mart’s offer of dinner and a movie: a $10 store gift card and a free one-night rental from redbox. “Every pharmacy needs to fill every prescription accurately,” said Michele Snider, senior director of pharmacy at Save Mart Supermarkets. “Our pharmacies already provide excellent customer service, and now our 19-Minute Promise will ensure that we also deliver prescriptions quickly.”
Save Mart Supermarkets operates 116 pharmacies in 250 stores in Northern California and Northern Nevada.
Study finds home delivery of prescriptions increases generics sales
NEW YORK Patients are more likely to use generic drugs if they get them from home delivery pharmacies rather than retail pharmacies, according to a study by pharmacy benefit manager Express Scripts, which operates a home delivery service.
The study found that patients using Sanofi-Aventis’ Ambien (zolpidem) or a generic version of the drug were 34 percent more likely to pick the generic version if they received it by home delivery.
“Financial incentives are important but not enough to realize the full money-saving potential of therapeutically equivalent generics,” study author Emily Cox said.